Genetic Biomarker May Predict Cancer Patients’ Response to Immunotherapy Drug
Researchers from Johns Hopkins Kimmel Cancer Center recently presented results from a Phase II clinical trial showing that in patients with colorectal cancers (CRCs) and other cancers for whom standard therapies ... Read more